ABVC BioPharma, Inc. Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement
ABVC BioPharma, Inc. (ABVC) had Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement of $681.18 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes
us-gaap:PrincipalAmountOutstandingOnLoansSecuritized · last filed 2025-04-30
- 2024-12-31: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $681.18K.
- 2024-09-30: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $606.32K.
- 2024-06-30: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $500.00K.
- 2024-03-31: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $681.18K; Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement as first filed $500.00K.
USD
| Period end | Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement | Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement as first filed |
|---|---|---|
| 2024-12-31 | $681.18K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $606.32K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $500.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $681.18K 10-Q · filed 2025-04-30 | $500.00K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $158.80K 10-Q · filed 2025-04-30 | $500.00K 10-Q · filed 2024-05-17 |
| 2022-06-30 | $1.00M 10-Q · filed 2022-08-15 |
TWD
| Period end | Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement |
|---|---|
| 2024-09-30 | 6.30M TWD 10-Q · filed 2024-11-14 |